Validation of a Genomic Classifier in the NRG Oncology/RTOG 0521 Phase III Trial of Docetaxel with Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer
| Autor: | Phillips, R., Proudfoot, J., Davicioni, E., Spratt, D.E., Feng, F.Y., Simko, J., Den, R.B., Pollack, A., Rosenthal, S.A., Sartor, O., Sweeney, C., Attard, G., Patel, S.I., Hall, W.A., Efstathiou, J.A., Shah, A.B., Hoffman, K.E., Pugh, S., Sandler, H.M., Tran, P.T. |
|---|---|
| Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 1 October 2023 117(2) Supplement:S34-S35 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|